SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ipca Laboratories informs about demise of independent director

03 Aug 2022 Evaluate

Ipca Laboratories has informed about the sad and sudden demise of the Independent Director, Dev Parkash Yadava yesterday evening at Mumbai. Yadava was the Non-Executive and Independent Director of the Company since April 2012. The Company has immensely benefited from his knowledge of pharma industry and guidance / advice given by him to the Company during his tenure of directorship all these years.

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories Share Price

1468.00 6.75 (0.46%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×